Literature DB >> 25269383

PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancer.

Thomas Wiegel1, Michael Stöckle2, Detlef Bartkowiak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25269383     DOI： 10.1016/j.eururo.2014.09.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  [PREFERE - Study on the rise].

Authors:  Carsten-H Ohlmann; Michael Stöckle; Peter Albers; Heinz Schmidberger; Martin Härter; Glen Kristiansen; Peter Martus; Stefan Wellek; Roswitha Bussar-Maatz; Thomas Wiegel
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

Review 2.  [Studies on localized low-risk prostate cancer : Do we know enough?]

Authors:  L Weißbach; C Roloff
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

3.  Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses.

Authors:  Karin A Wasmann; Pieta Wijsman; Susan van Dieren; Willem Bemelman; Christianne Buskens
Journal:  BMJ Open       Date:  2019-10-16       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.